BBAAY
Alibaba Group Holding Ltd
No data for this timeframe.
Vol
SEC Reports9
Recent Activity
Jun 9, 2026
SEC
Alibaba Group disclosed via 6-K that the U.S. Department of Defense has added it to the Chinese Military Companies (CMC)
6-K — Impact 6/10
Jun 1, 2026
SEC
Alibaba granted 61,716,712 restricted share units (0.32% of outstanding shares) to employees under the 2024 Plan on May
6-K — Impact 3/10
May 28, 2026
SEC
Alibaba filed a 6-K providing dividend distribution logistics for its previously declared FY2026 annual regular cash div
6-K — Impact 2/10
Analyst Ratings
13Strong Buy
30Buy
4Hold
1Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
9 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 0 mixed, 6 neutral. Avg impact: 3.8/10.
BEARISH
6-K
6/10
Alibaba Group disclosed via 6-K that the U.S. Department of Defense has added it to the Chinese Mili
Jun 9, 2026
NEUTRAL
6-K
3/10
Alibaba granted 61,716,712 restricted share units (0.32% of outstanding shares) to employees under t
Jun 1, 2026
NEUTRAL
6-K
2/10
Alibaba filed a 6-K providing dividend distribution logistics for its previously declared FY2026 ann
May 28, 2026
NEUTRAL
6-K
2/10
Alibaba filed a routine 6-K furnishing a Hong Kong Stock Exchange Next Day Disclosure Return for a d
May 22, 2026
BEARISH
20-F
7/10
Alibaba filed its annual 20-F for FY2026 (year ended March 31, 2026), reporting full-year revenue of
May 20, 2026
BEARISH
6-K
7/10
Alibaba reported March quarter FY2026 revenue of RMB243.4B (+3% YoY, +11% like-for-like), but operat
May 13, 2026
NEUTRAL
6-K
3/10
Alibaba received HKEx approval to proceed with the spin-off of its Jiaxing Park logistics asset via
Apr 27, 2026
NEUTRAL
6-K
2/10
Alibaba Group issued 58,084,712 new shares between March 31 and April 21, 2026, primarily through em
Apr 24, 2026
NEUTRAL
6-K
2/10
Alibaba Group filed a routine monthly return for March 2026, disclosing standard share capital and s
Apr 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 90% buy across 48 analysts — 13 strong buy, 30 buy, 4 hold, 1 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 13 | 30 | 4 | 1 | 0 | 90% | |
| May 1, 2026 | 13 | 29 | 4 | 1 | 0 | 89% | |
| Apr 1, 2026 | 13 | 28 | 5 | 1 | 0 | 87% | |
| Mar 1, 2026 | 15 | 26 | 6 | 1 | 0 | 85% | |
| Feb 1, 2026 | 15 | 26 | 6 | 1 | 0 | 85% | |
| Jan 1, 2026 | 15 | 27 | 5 | 1 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.